Quick Answer
Aurinia Pharmaceuticals Inc. reported Earnings Per Share Diluted of $2.07 per share for the year ending 2025.
- Aurinia Pharmaceuticals Inc. showed an increase of +5,075.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Aurinia Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Aurinia Pharmaceuticals Inc.'s Earnings Per Share Diluted has grown by 317.9%.
- Historical annual values: Fiscal year 2025: $2.07 per share | Fiscal year 2024: $0.04 per share | Fiscal year 2023: $0.54 (loss) per share | Fiscal year 2022: $0.76 (loss) per share | Fiscal year 2021: $1.40 (loss) per share | Fiscal year 2020: $0.87 (loss) per share | Fiscal year 2019: $0.95 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: